drugset
drugset / Trial / NCT04468815

A Study to Assess the Levels in Blood Plasma of BMS-986278 in Healthy Participants Following Administration of Tablets, With or Without Food, and in the Presence of an Antacid (Esomeprazole)

NCT04468815 ↗

Phase 1 Completed 24 enrolled Bristol-Myers Squibb
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to assess levels in blood plasma of BMS-986278 and the food effect in healthy participants.

Timeline

Start
2020-07-10
Primary completion
2020-10-07
Completion
2020-10-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Admilparant Small molecule — —
Subject Esomeprazole Small molecule — —

Indications

No indication recorded.